Science Explorer Back to mapMap

COVID-19 epidemiological studies

COVID-19 epidemiological studies is a research topic within Modeling and Simulation. Science Explorer counts 40k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on mathematical modeling, analysis, and forecasting of the transmission dynamics, public health interventions, and epidemiological characteristics of the COVID-19 pandemic. It includes studies on the impact of various factors such as temperature, humidity, social distancing, and travel restrictions on the spread of the virus.

  • COVID-19
  • modeling
  • transmission dynamics
  • public health interventions
  • epidemiology
  • infectious diseases
  • social distancing
  • mathematical analysis
  • pandemic control
  • viral spread
Research works
40k
fractional, since 1950
In the world top 10%
4k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+2%
the tick is no change
Largest producer
United States
29% of the 10 largest, 2022-now

Which countries lead COVID-19 epidemiological studies research?

By volume, the United States and China publish the most (2.8k and 1.9k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.8k works
  2. 2 China 1.9k works
  3. 3 India 1.6k works
  4. 4 United Kingdom 818 works
  5. 5 Italy 464 works
  6. 6 Nigeria 453 works
  7. 7 Canada 437 works
  8. 8 Germany 402 works
  9. 9 Brazil 392 works
  10. 10 Japan 376 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.4%China: 19.5%India: 16.5%United Kingdom: 8.5%6 others listed: 26.1%29%largest
United States2,849 · 29.4%China1,889 · 19.5%India1,596 · 16.5%United Kingdom818 · 8.5%6 others listed2,523 · 26.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead COVID-19 epidemiological studies research?

By volume in 2022-now, Centre National de la Recherche Scientifique publishes the most COVID-19 epidemiological studies research, followed by University of North Carolina at Chapel Hill and United States Department of Health and Human Services.

Who are the leading researchers in COVID-19 epidemiological studies?

The most-cited researchers publishing on COVID-19 epidemiological studies include Christopher J L Murray, Yoshua Bengio and Rob Knight.

  1. 1 Christopher J L Murray United States 583k citations
  2. 2 Yoshua Bengio Canada 476k citations
  3. 3 Rob Knight United States 468k citations
  4. 4 Simon Iain Hay United States 452k citations
  5. 5 Theo Vos United States 439k citations
  6. 6 George Davey Smith United Kingdom 435k citations
  7. 7 Ali H. Mokdad United States 429k citations
  8. 8 Stacey L. Gabriel United States 402k citations
  9. 9 Robert John Tibshirani United States 396k citations
  10. 10 Zulfiqar Ahmed Bhutta Pakistan 371k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in COVID-19 epidemiological studies?

The most cited paper in COVID-19 epidemiological studies is "Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China" (Zunyou Wu, Jennifer M. McGoogan, 2020), with 18,071 citations. Next come "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia" (18,005) and "The global distribution and burden of dengue" (10,418).

Most cited papers
#PaperReleasedCitations
1 Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Zunyou Wu, Jennifer M. McGoogan · JAMA Open access 24 Feb 2020 18,071
2 Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia Qun Li et al. · New England Journal of Medicine Open access 29 Jan 2020 18,005
3 The global distribution and burden of dengue Samir Bhatt, Peter W. Gething, Oliver J. Brady et al. · Nature Open access Apr 2013 10,418
4 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Neeltje van Doremalen, Trenton Bushmaker, Dylan H. Morris et al. · New England Journal of Medicine Open access 17 Mar 2020 10,255
5 Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission Pauline Van den Driessche, James Watmough · Mathematical Biosciences Nov 2002 10,191
All 100 most cited papers, with filters and sorting

Where is COVID-19 epidemiological studies research done?

The largest centres of COVID-19 epidemiological studies research in 2022-now are Beijing (China), London (United Kingdom), Dhaka (Bangladesh) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Abuja.

Largest cities, 2022-now

  1. 1 BeijingChina 319 works
  2. 2 LondonUnited Kingdom 305 works
  3. 3 DhakaBangladesh 166 works
  4. 4 New DelhiIndia 162 works
  5. 5 ParisFrance 149 works
  6. 6 AtlantaUnited States 139 works
  7. 7 TokyoJapan 136 works
  8. 8 New YorkUnited States 135 works
  9. 9 ShanghaiChina 131 works
  10. 10 Washington D.C.United States 119 works

Where it is the local speciality

  1. AbujaNG · 38.8 works8.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in COVID-19 epidemiological studies than the world average.

See COVID-19 epidemiological studies on the map

Where is the best place to study COVID-19 epidemiological studies?

Among universities, judged by research, Debre Berhan University, Lebanese American University and Indian Institute of Engineering Science and Technology, Shibpur score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 26.47%fractional works in this field (log) →share of work in the world top 10% →Debre Berhan Univers…Indian Institute of …Lebanese American Un…London School of Hyg…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Debre Berhan UniversityEthiopia 65.246.9%19.8×10 +126.6%
2Lebanese American UniversityLebanon 59.026.4%7.8×12 +885.4%
3Indian Institute of Engineering Science and Technology, ShibpurIndia 58.739.8%10.1×15 +16.1%
4London School of Hygiene & Tropical MedicineUnited Kingdom 58.212.9%21.9×49 -22.4%
5Osun State UniversityNigeria 56.426.1%18.7×19 +935.9%
6Prince Sultan UniversitySaudi Arabia 55.928.2%7.0×11 +69.1%
7Johns Hopkins UniversityUnited States 54.815.7%3.0×66 -2.6%
8Government College University, LahorePakistan 54.635.3%6.3×8 +91.1%
9University of Hong KongChina 54.417.0%3.2×43 -15.5%
10Harvard UniversityUnited States 52.316.4%1.5×68 -29.0%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in COVID-19 epidemiological studies, country by country

Is COVID-19 epidemiological studies research growing?

Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are COVID-19 epidemiological studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is COVID-19 epidemiological studies as a percentage of every work published that year, 0.057% in 2024.

still counting0.050%0.10%0.15%COVID-19 epidemiological studies0.043% in 202519801990200020102020

Fractional works of COVID-19 epidemiological studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%COVID-19 epidemiological studies10.2% in 202520102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about COVID-19 epidemiological studies. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.